DV
Dividend Vision

CBLL — CeriBell, Inc

CeriBell, Inc (CBLL)

Total return is 37.2% over the past 1.8 years, 0.3 points behind SPY at 37.5%. Its deepest 1-year drawdown was 30.5%.

CeriBell, Inc. is a medical technology company that develops the Ceribell System, a point-of-care EEG platform designed for acute care settings, along with related disposable headbands, a portable EEG recorder, and an AI-powered seizure detection algorithm. The company does not currently distribute dividends to shareholders. CeriBell appeals to growth-oriented investors seeking exposure to medical device innovation in the neurology sector, rather than those focused on income generation.

CBLL key facts

Asset type
Stock
Asset class
Equity
Inception date
10/10/2024
Last close
$23.33
Market cap
$710,287,296
Average volume
296000.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-1.62